Clinical Trial Update: Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and pharmacokinetics of intraoperative hyperthermic intraperitoneal chemotherapy using cisplatin to treat platinum-sensiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Ovarian Cancer | Phase 1 | Status: UNKNOWN